[Image courtesy of Adobe Stock]
A recession in 2023 is highly probable. Some two-thirds of economists surveyed at the World Economic Forum in Davos said they anticipated an economic downturn this year.Given the difficult economic situation, a growing number of pharmaceutical firms are reducing staff. Several companies announced cuts at the end of 2022, including Catalent and Novartis.
The following is a list of some significant pharma layoffs announced at the outset of 2023.
Amgen cuts 300 workersThe company is undergoing a restructuring effort that includes layoffs of around 300 employees. The pharma layoffs will primarily affect employees in the commercial team based in the U.S., according to a report obtained from Endpoints.
Merck KGaA lays off 133Merck KGaA, Darmstadt, Germany, is letting go of 133 jobs in Billerica, Massachusetts, as part of a restructuring effort, according t…